Opening book details…
About this Medicine article
Cabozantinib als neue Option beim mit TKI vortherapierten Nierenzellkarzinom by Dr. med. Martin Boegemann is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Dr. med. Martin Boegemann
- Publisher
- Springer; Springer-Verlag; Springer Verlag; Springer Science and Business Media LLC (ISSN 0947-8965)
- Published
- 2017
- Language
- DE
- Field
- Medicine (Health Sciences)